Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Splenectomy unveils thrombocytosis in underlying myeloproliferative neoplasms with extrahepatic portal vein obstruction.
Shimizu T, Yoshida H, Taniai N, Ohashi R, Kawano Y, Ueda J, Iwai T, Matsushita A, Yoshioka M, Murokawa T, Irie T, Ono T, Haruna T, Yoshimori D, Hamaguchi A. Shimizu T, et al. Among authors: yoshida h. Intractable Rare Dis Res. 2024 Aug 31;13(3):165-171. doi: 10.5582/irdr.2024.01013. Intractable Rare Dis Res. 2024. PMID: 39220273 Free PMC article.
Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitis.
Futagami S, Agawa S, Nakamura K, Watanabe Y, Habiro M, Kawawa R, Yamawaki H, Tsushima R, Kirita K, Akimoto T, Ueki N, Tomohide T, Itokawa N, Suzuki N, Naito Y, Takeuchi K, Kashiro A, Ohta R, Mizutani S, Taniai N, Yoshida H, Iwakiri K, Honda K. Futagami S, et al. Among authors: yoshida h. J Gastroenterol Hepatol. 2023 Nov;38(11):1949-1957. doi: 10.1111/jgh.16302. Epub 2023 Jul 27. J Gastroenterol Hepatol. 2023. PMID: 37501507
Clinical features of extrahepatic portal vein obstruction: Myeloproliferative neoplasms eliminate hypersplenic hematologic changes in extrahepatic portal vein obstruction.
Shimizu T, Yoshida H, Taniai N, Yoshioka M, Kawano Y, Matsushita A, Ueda J, Iwai T, Murokawa T, Ono T, Hamaguchi A. Shimizu T, et al. Among authors: yoshida h. Intractable Rare Dis Res. 2024 Feb;13(1):63-68. doi: 10.5582/irdr.2023.01106. Intractable Rare Dis Res. 2024. PMID: 38404733 Free PMC article.
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.
Ando F, Kashiwada T, Kuroda S, Fujii T, Takano R, Miyabe Y, Kunugi S, Sakatani T, Miyanaga A, Asatsuma-Okumura T, Hashiguchi M, Kanazawa Y, Ohashi R, Yoshida H, Seike M, Gemma A, Iwai Y. Ando F, et al. Among authors: yoshida h. Front Pharmacol. 2024 May 7;15:1384731. doi: 10.3389/fphar.2024.1384731. eCollection 2024. Front Pharmacol. 2024. PMID: 38774209 Free PMC article.
Short-term and three-year long-term outcomes of laparoscopic surgery versus open surgery for obstructive colorectal cancer following self-expandable metallic stent placement: a meta-analysis.
Kanaka S, Yamada T, Matsuda A, Uehara K, Shinji S, Yokoyama Y, Takahashi G, Iwai T, Takeda K, Kuriyama S, Miyasaka T, Yoshida H. Kanaka S, et al. Among authors: yoshida h. Surg Endosc. 2024 Oct;38(10):5514-5527. doi: 10.1007/s00464-024-11187-x. Epub 2024 Aug 29. Surg Endosc. 2024. PMID: 39210057 Free PMC article. Review.
Risk Factors for Adhesive Small Bowel Obstruction After Liver Cancer Surgery.
Yukawa N, Yamada T, Ichikawa D, Aoyama T, Kataoka K, Shioya T, Tamura T, Shimoyama R, Fukazawa A, Kumamoto K, Yamashita N, Hasegawa S, Saito S, Takemasa I, Fujita F, Taniai N, Kaibori M, Yoshida H. Yukawa N, et al. Among authors: yoshida h. Cancer Diagn Progn. 2024 Nov 3;4(6):689-695. doi: 10.21873/cdp.10383. eCollection 2024 Nov-Dec. Cancer Diagn Progn. 2024. PMID: 39502609 Free PMC article.
7,988 results